MR imaging of ovarian tumors using folate-receptor-targeted contrast agents

[1]  E. Kim,et al.  Molecular and Cellular MR Imaging , 2007, Journal of Nuclear Medicine.

[2]  A. Huvos,et al.  The Folate Receptor α Is Frequently Overexpressed in Osteosarcoma Samples and Plays a Role in the Uptake of the Physiologic Substrate 5-Methyltetrahydrofolate , 2007, Clinical Cancer Research.

[3]  Isabelle Raynal,et al.  Superparamagnetic Contrast Agents , 2007 .

[4]  M. Wendland,et al.  MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent. , 2007, Contrast media & molecular imaging.

[5]  M. Ratnam,et al.  The folate receptor: What does it promise in tissue-targeted therapeutics? , 2007, Cancer and Metastasis Reviews.

[6]  M. Brechbiel,et al.  Specific targeting of folate–dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[7]  S. Ametamey,et al.  Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  R. Schibli,et al.  Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  S. Okarvi,et al.  Preparation and in vitro and in vivo evaluation of technetium-99m-labeled folate and methotrexate conjugates as tumor imaging agents. , 2006, Cancer biotherapy & radiopharmaceuticals.

[10]  M. Green,et al.  Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid. , 2005, Journal of the American Chemical Society.

[11]  R. Weissleder,et al.  Detection of Dysplastic Intestinal Adenomas Using a Fluorescent Folate Imaging Probe , 2005, Molecular imaging.

[12]  P. Low,et al.  Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery , 2004, Molecular Pharmacology.

[13]  Rong Zhou,et al.  Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. , 2004, Academic radiology.

[14]  J. Reddy,et al.  Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  Isabelle Raynal,et al.  Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10 , 2004, Investigative radiology.

[16]  D. Kranz,et al.  Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice , 1997, Journal of Neuro-Oncology.

[17]  P. Low,et al.  Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. , 2003, Journal of biomedical optics.

[18]  S. Canevari,et al.  Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies , 2003, Gene Therapy.

[19]  Woo Kyung Moon,et al.  Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. , 2003, Bioconjugate chemistry.

[20]  D. Goldman,et al.  Membrane transport of folates. , 2003, Vitamins and hormones.

[21]  J. Reddy,et al.  Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical. , 2002, Bioconjugate chemistry.

[22]  Woo Kyung Moon,et al.  A Receptor‐Targeted Near‐Infrared Fluorescence Probe for In Vivo Tumor Imaging , 2002, Chembiochem : a European journal of chemical biology.

[23]  M. Brechbiel,et al.  Imaging folate binding protein expression with MRI. , 2002, Academic radiology.

[24]  F. Behm,et al.  Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia. , 2000, Blood.

[25]  E C Wiener,et al.  Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress. , 2000, Investigative radiology.

[26]  W. Guo,et al.  99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  W. Gunning,et al.  Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  P. Low,et al.  Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  A. Russo,et al.  Expression of folate binding protein as a prognostic factor for response to platinum‐containing chemotherapy and survival in human ovarian cancer , 1998, International journal of cancer.

[30]  E C Wiener,et al.  Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. , 1997, Investigative radiology.

[31]  A. Tomassetti,et al.  Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines , 1997, Journal of cellular biochemistry.

[32]  G Toffoli,et al.  Overexpression of folate binding protein in ovarian cancers , 1997, International journal of cancer.

[33]  A. Antony,et al.  Folate receptors. , 1996, Annual review of nutrition.

[34]  C. Meijer,et al.  Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissue. , 1995, Journal of clinical pathology.

[35]  J. Ross,et al.  Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications , 1994, Cancer.

[36]  J. Ross,et al.  Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. , 1994, Biochemistry.

[37]  L R Coney,et al.  Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.

[38]  A. Antony,et al.  The biological chemistry of folate receptors. , 1992, Blood.

[39]  S. Rothenberg,et al.  Characterization of multiple forms of folate-binding protein from human leukemia cells. , 1986, Biochimica et biophysica acta.